A bridge too far: We have not overstepped the line for extended deceased donors

Liver Transplantation

Volumn 20, Issue S2, 2014, Pages S9-S13

  Fondevila, Constantino ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CADAVER DONOR; COLD ISCHEMIA; DIABETES MELLITUS; FATTY LIVER; HEART DEATH; HEPATITIS; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERNATREMIA; HYPERTENSION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MULTIPLE ORGAN FAILURE; SEROLOGY; SPLIT LIVER TRANSPLANTATION; ADVERSE EFFECTS; AGE; CAUSE OF DEATH; DONOR; DONOR SELECTION; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HEALTH CARE DELIVERY; HEALTH STATUS; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SUPPLY AND DISTRIBUTION; TREATMENT OUTCOME;

AGE FACTORS; CAUSE OF DEATH; DONOR SELECTION; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS; HUMANS; LIVER TRANSPLANTATION; RISK ASSESSMENT; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84911430424     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24000     Document Type: Article

References (15)

1. Saidi RF, Bradley J, Greer D, Luskin R, O'Connor K, Delmonico F, et al. Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant 2010;10:2536-2540.
2. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002;36:202-210.
3. Jay CL, Lyuksemburg V, Kang R, Preczewski L, Stroupe K, Holl JL, et al. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg 2010;251:743-748.
4. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
5. Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006;244:439-450.
6. Grazi GL, Cescon M, Ravaioli M, Ercolani G, Pierangeli F, D'Errico A, et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 2001;1:61-68.
7. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105-113.
8. Imura S, Shimada M, Ikegami T, Morine Y, Kanemura H. Strategies for improving the outcomes of small-for-size grafts in adult-to-adult living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2008;15:102-110.
9. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990;212:368-375.
10. Hashimoto K, Quintini C, Aucejo FN, Fujiki M, Diago T, Watson MJ, et al. Split liver transplantation using hemi-liver graft in the MELD era: a single center experience in the United States. Am J Transplant; doi 10.1111/ajt.12791.
11. Fondevila C, Hessheimer AJ, Ruiz A, Calatayud D, Ferrer J, Charco R, et al. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant 2007;7:1849-1855.
12. Fondevila C, Hessheimer AJ, Flores E, Ruiz A, Mestres N, Calatayud D, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant 2012;12:162-170.
13. Fondevila C, Hessheimer AJ, Maathuis MH, Munoz J, Taura P, Calatayud D, et al. Superior preservation of DCD livers with continuous normothermic perfusion. Ann Surg 2011;254:1000-1007.
14. Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001; 7:762-768.
15. Prieto M, Gomez MD, Berenguer M, Cordoba J, Rayon JM, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001; 7:51-58.